Back to results
US 2007/0166757 A1Published application
Relaxin as an independent risk factor predicting mortality
AssigneeBayer HealthCare LLC
InventorsJohannes-Peter Stasch, Mathias Gehrmann, Berthold Hocher
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of characterising life expectancy of human individuals on the basis of measured relaxin levels. In one aspect of the invention the human individuals are end-stage-kidney-disease patients.
Claims11
Method of characterising the life expectancy of a human individual, comprising the steps of
- (a) determining the level of relaxin in said human individual,
- (b) comparing said level of relaxin with predetermined data, and
- (c) characterising the life expectancy of said human individual based on said comparison.
Method of increasing the life expectancy of a human individual by administering a pharmaceutical composition comprising a relaxin inhibiting agent.
Dependencies are inferred from the claim text.